ClinicalTrials.gg
RecruitingNCT07536399Updated Jul 29, 2026

Biologic Augmentation of TMJ Arthroscopy Using BMAC

A Phase 3 interventional study of Bone Marrow Aspirate Concentrate and Corticosteroid (CS) in TMJ - Oral &Maxillofacial Surgery, Oral and Maxillofacial Conditions and TMJ Pain, sponsored by Weill Medical College of Cornell University. Recruiting at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-07-29.

Sponsored by Weill Medical College of Cornell University · Phase 3, Interventional, and Treatment

How we know

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 106 studies in Arthralgia with a site in United States — 17 open to participants now, 23 under way, 4 of them phase 3. Arthralgia · United States.

Planned enrollment
66th of 88
20 · median 82
Started
2026
with 7 others
Phase 3
19 of 106
2 open now
Primary completion
2027-12
later than 14 of 22 live
Registered
102nd of 106
by date

Among the 106 studies in Arthralgia with a site in United States, this one is the 66th largest by planned enrollment of the 88 interventional ones that give a count, is one of 8 that started in 2026, is one of 19 in phase 3, reaches primary completion later than 14 of the 22 other live ones, and was the 102nd registered.

Arthralgia

277 studies on the registry are indexed under Arthralgia; 54 are open to participants now.

Browse Arthralgia studies →

Open to participants now

17 of the 106 studies in Arthralgia with a site in United States are open now. Recruiting first, the newest first:

11 more — sign in →

All 17 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 35 Arthralgia studies recruiting now, 18 (51%) set no upper age limit and 16 (46%) stop at 75 or younger; 1 takes children under 18; 9 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 106 studies in Arthralgia with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn about the efficacy of using Bone Marrow Aspirate Concentrate (BMAC) during temporomandibular joint (TMJ) arthroscopy compared to standard arthroscopic procedures with corticosteroid (CS) injections in patients with pain (arthralgia) of the temporomandibular joint (TMJ) that has failed to respond to conservative treatment. The main question it aims to answer:

Does BMAC injection reduce the amount of inflammation and structural damage in the TMJ? Researchers will compare BMAC injection to corticosteroid injections see if BMAC injection helps .

Participants will :

  • Be randomized to receive either BMAC or CS injection during TMJ arthroscopy
  • Visit the clinic for 3 follow up visits over 6 months and answer questionnaires
  • have 2 MRIs of their jaw
03

Conditions studied

  • TMJ - Oral &Maxillofacial Surgery
  • Oral and Maxillofacial Conditions
  • TMJ Pain
  • TMJ Arthralgia

Browse trials for

Keywords

  • TMJ pain
  • Oral and maxillofacial conditions
  • TMJ arthroscopy
  • bone marrow aspirate concentrate
  • BMAC
  • steroid
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Participant is at least 18 years of age and not older than 75 years of age
  2. Participant is willing and able to provide written to participant in this study
  3. Participant has symptoms of TMJ arthralgia (pain) with significant temporomandibular joint pain and dysfunction despite at least 30 days of conservative therapy (NSAIDS, muscle relaxants, bite splints, PT, warm compresses, soft diet, etc.)
  4. Participant has baseline pain of ≥30 on a 100mm visual analog scale (VAS)

Exclusion criteria

Exclusion Criteria:

  1. Participant has not competed at least 30 days of conservative therapy
  2. Participant was diagnosed with central or neuropathic pain disorder
  3. Participant has a primary diagnosis of myofascial pain
  4. Participant has fibromyalgia
  5. Participant is pregnant or breastfeeding
  6. Participant had traumatic injury to the masticatory muscles or temporomandibular joint within 12 months of screening
  7. Participant who has the following to MRI:

    • Electrical implants such as cardiac pacemakers or perfusion pumps
    • Ferromagnetic implants such as aneurysm clips, surgical clips, prostheses, artificial heart, valves with steel parts, metal fragments, shrapnel, bullets, tattoos near the eye, or steel implants
    • History of seizures
    • Patients with \< 15 ml/min/1.73m2 or who are on dialysis will be excluded from the study.
    • Allergy to contrast die
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

GFR and eGFR (kidney filtering)

GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².

Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    BMAC Arm

    Participants in this arm will receive BMAC injection during their TMJ arthroscopy procedure

    Biological: Bone Marrow Aspirate Concentrate

  • Active comparator
    Corticosteroid Arm

    Participants in this arm will receive steroid injection during their TMJ arthroscopy procedure

    Drug: Corticosteroid (CS)

Interventions

  • BiologicalBone Marrow Aspirate Concentrate

    Single dose injection of bone marrow fluid from the participant's anterior iliac crest (hip) into the TMJ area during arthroscopy.

  • DrugCorticosteroid (CS)

    Single dose injection of cortiosteroid into the TMJ area during arthroscopy.

06

What researchers measure

Primary outcomes

  1. Change from Baseline in Kellenberger score at 6 Months.

    Participant MRIs will be given a Kellenberger score of 0-13. A higher Kellenberger scores indicate a higher degree of inflammation and damage.

    Time frame: Baseline; 6 months

Secondary outcomes

  1. Change in Maximum interincisal opening (MIO)

    Distance measured on a ruler between the incisal edges in millimeters

    Time frame: Baseline , Procedure, 3 weeks post-op, 3 months post-op, 6 months post-op

  2. Change in Pain Scores

    Pain on Visual analogue score. Zero is equivalent to no pain and 10 indicates the worst possible pain.

    Time frame: Baseline, Procedure, 3 weeks post-op, 3 months post-op, 6 months post-op

  3. Change in Jaw Functional Limitation Scale (JFLS) Score

    JFLS is an 8 question survey on jaw functionality scored from 0 (no limitation) to 10 (severe limitation).

    Time frame: Baseline, Procedure, 3 weeks post-op, 3 months post-op, 6 months post-op

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2026 (actual). Primary completion is estimated for Dec 2027, 19 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 10, 2026
First posted
Apr 17, 2026
StartActual
May 1, 2026
Primary completionEst.
Dec 2027
CompletionEst.
Jun 2028
Last update
Jul 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07536399
Collaborators
Oral and Maxillofacial Surgery Foundation, Rosemont ,Illinois
Responsible party
Sponsor
First posted
Apr 17, 2026
Start date
May 1, 2026
Primary completion
Dec 2027 (estimated)
Completion
Jun 2028 (estimated)
Last update
Jul 29, 2026

Study contacts

Jordan Augsburger
Contact
JOA7035@MED.CORNELL.EDU
212.746.5175
Gwendolyn Reeve, DMD
principal investigator · Weill Medical College of Cornell University

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion